A detailed history of Procyon Advisors, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 3,252 shares of LNTH stock, worth $294,371. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,252
Previous 2,803 16.02%
Holding current value
$294,371
Previous $225,000 58.22%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$77.7 - $123.62 $34,887 - $55,505
449 Added 16.02%
3,252 $356,000
Q2 2024

Aug 02, 2024

BUY
$58.87 - $83.05 $165,012 - $232,789
2,803 New
2,803 $225,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.